Publications by authors named "L Cea-Calvo"

Stress urinary incontinence (SUI) is common in women with chronic cough but may be overlooked. To determine the frequency of underdiagnosis of cough-related SUI and its impact on women's general health status and quality of life (QoL). Data were analyzed for 147 women with refractory/unexplained chronic cough.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigates how the severity of chronic cough affects the quality of life (QoL) and other outcomes for Spanish patients with refractory chronic cough (RCC) or unexplained chronic cough (UCC).
  • Patients self-reported cough severity using various tools, and their results were categorized into three groups based on cough severity scores, revealing a direct link between higher severity and worse QoL.
  • The findings suggest that patients with more severe coughs reported greater negative impacts on their daily lives, indicating they may need more targeted treatment interventions.
View Article and Find Full Text PDF

People with (a cough lasting more than 8 weeks) are often referred to different specialists and undergo numerous diagnostic tests, but clear guidance is lacking. This work summarizes a consensus (an agreement) among medical specialists who are involved in managing people with : physicians (family doctors), pulmonologists (doctors who specialize in lung conditions), allergists (medical professionals specializing in allergies) and ear, nose and throat (ENT) specialists. They discussed how to perform a basic assessment of people with in (day-to-day healthcare given by a general practitioner or family doctor) and how to refer them to different specialists based on clinical findings or test results.

View Article and Find Full Text PDF

Background: The early identification of patients' profiles most likely to respond to and maintain long-term therapy with a biological drug can have clinical and cost-effectiveness implications.

Objectives: To evaluate the utility of an innovative approach for early identification of patient profiles associated with long-term persistence of golimumab, a tumour necrosis factor inhibitor, in patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), and axial spondyloarthritis (SpA) under real-world conditions.

Design: Retrospective non-interventional database analysis.

View Article and Find Full Text PDF